| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.2M | -10.7% |
| Cost of Revenue | $3.2M | +16.8% |
| R&D Expense | $14.3M | -28.8% |
| SG&A Expense | $21.6M | -17.6% |
| Operating Income | -$33.6M | +20.1% |
| Pre-tax Income | -$34.3M | +18.9% |
| Income Tax | -$571K | +0.0% |
| Net Income | -$32.8M | +27.4% |
| EPS (Basic) | -$13.04 | -649.4% |
| EPS (Diluted) | -$13.04 | -649.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.0M | +455.9% |
| Short-term Investments | $135K | -93.9% |
| Accounts Receivable | $143K | -61.8% |
| Inventory | $199K | -78.1% |
| Current Assets | $3.3M | -31.5% |
| Total Assets | $39.2M | -23.2% |
| Current Liabilities | $24.3M | +140.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.0M | +17.5% |
| Capital Expenditures | $875K | -55.9% |
| Investing Cash Flow | $1.2M | -96.2% |
| Financing Cash Flow | $25.6M | +386.4% |
| Free Cash Flow | -$26.9M | +19.8% |
| Total Liabilities |
| $37.5M |
| +64.9% |
| Stockholders' Equity | $6.3M | -79.9% |